User:Saci94/sandbox

History
Created in 2019, Piahuy Labs is an European pharmaceutical  and medical cannabis company headquartered in Lisbon with operations in Aveiro, Portugal.

In  2020, Piauhy Labs  received its pre-licence from the Infarmed - Portuguese National Authority of Medicines and Health Products.

Piahuy Labs  is an European based, science driven medical cannabis company, committed to producing high quality, personalized medicine.

The firm is positioned at the crossroad of biotechnology, neuroscience, and medicinal cannabis.

On May 2021 it completed its latest funding round company led by Migration Capital a private investment company based in the Greater Boston Area.

Founder
Eduardo Sampaio  (CEO)

Research
Piauhy labs aims to bring more science to the Cannabis Industry. R&D is one of the pillars of the company. The Scientific Committee includes Professor Sidarta Ribeiro acting as ‘scientific consultant,’ a renowned neuroscientist and founder of the Brain Institute and Elmo Resende PhD in Analytical Chemistry

Despite significant advances in research several diseases remain untreated still. Piahuy research program’s purpose  is to target the ECS (endocannabinoid system) and explore  new treatments for disorders of the CNS (central nervous system) such as:

For Alzheimer

Epilepsy

ASD (Autism)

Methodologies
Creation of cannabinoids through the method of biosynthesis

Animal model studies for Autism (ASD) and Epilepsy

Analytical chemistry and separation methods for minor cannabinoids.

Development of mAbs (monoclonal antibodies) targeting CB2 receptors and its regulation of inflammatory response

Personalized Medicine to provide tailored treatment.

Press
https://canaltech.com.br/saude/a-futura-industria-da-cannabis-no-brasil-e-o-desafio-do-alto-preco-dos-produtos-160862/

https://epoca.globo.com/grupo-aguarda-decisao-da-anvisa-para-investir-em-remedios-base-de-maconha-23725610

https://veja.abril.com.br/blog/cannabiz/a-cannabis-do-vizinho-e-sempre-mais-verde/

https://www1.folha.uol.com.br/mercado/2020/12/flexibilizacao-de-regras-provocou-duas-bolhas-na-industria-mundial-da-erva.shtml

https://www.smokebuddies.com.br/a-futura-industria-da-cannabis-no-brasil-e-o-desafio-do-alto-preco/